We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Matrixx Case Puts Much at Stake for Drugmakers, FDA
Matrixx Case Puts Much at Stake for Drugmakers, FDA
September 3, 2010
As the Supreme Court prepares to hear arguments in a shareholder lawsuit against Matrixx Initiatives, the industry as a whole is bracing itself for a ruling that could dramatically increase the amount of information companies provide to the public and change the FDA’s role in monitoring drug safety.